OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The effect of CYP3A4 genetic polymorphism and drug interaction on the metabolism of istradefylline
Xiaoqin Hu, Jinhuan Ni, Nanyong Gao, et al.
Chemico-Biological Interactions (2022) Vol. 366, pp. 110123-110123
Closed Access | Times Cited: 7
Xiaoqin Hu, Jinhuan Ni, Nanyong Gao, et al.
Chemico-Biological Interactions (2022) Vol. 366, pp. 110123-110123
Closed Access | Times Cited: 7
Showing 7 citing articles:
Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy
Christian Griñán‐Ferré, Aina Bellver‐Sanchís, Ana Guerrero, et al.
Pharmacological Research (2024) Vol. 205, pp. 107247-107247
Open Access | Times Cited: 12
Christian Griñán‐Ferré, Aina Bellver‐Sanchís, Ana Guerrero, et al.
Pharmacological Research (2024) Vol. 205, pp. 107247-107247
Open Access | Times Cited: 12
CYP3A4 and CYP3A5: the crucial roles in clinical drug metabolism and the significant implications of genetic polymorphisms
Yuqing Zhang, Ziying Wang, Yuanchao Wang, et al.
PeerJ (2024) Vol. 12, pp. e18636-e18636
Open Access | Times Cited: 6
Yuqing Zhang, Ziying Wang, Yuanchao Wang, et al.
PeerJ (2024) Vol. 12, pp. e18636-e18636
Open Access | Times Cited: 6
Impact of CYP3A4 functional variability on ziprasidone metabolism
Qi Zhou, Yameng Wu, Zhize Ye, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Qi Zhou, Yameng Wu, Zhize Ye, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Drug-induced enzyme activity inhibition and CYP3A4 genetic polymorphism significantly shape the metabolic characteristics of furmonertinib
Qi Zhou, Zhize Ye, Xiaoyu Xu, et al.
Toxicology (2024) Vol. 507, pp. 153903-153903
Closed Access | Times Cited: 2
Qi Zhou, Zhize Ye, Xiaoyu Xu, et al.
Toxicology (2024) Vol. 507, pp. 153903-153903
Closed Access | Times Cited: 2
Gene polymorphisms and drug-drug interactions determine the metabolic profile of blonanserin
Feng Ye, Xinyue Li, Jinhuan Ni, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 388, Iss. 1, pp. 190-200
Open Access | Times Cited: 5
Feng Ye, Xinyue Li, Jinhuan Ni, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 388, Iss. 1, pp. 190-200
Open Access | Times Cited: 5
Bioinformatics approach and experimental validation reveal the hepatoprotective effect of pachyman against acetaminophen-associated liver injury
Ka Wu, Jingru Qin, Meizhen Liu, et al.
Aging (2023) Vol. 15, Iss. 17, pp. 8800-8811
Open Access | Times Cited: 3
Ka Wu, Jingru Qin, Meizhen Liu, et al.
Aging (2023) Vol. 15, Iss. 17, pp. 8800-8811
Open Access | Times Cited: 3
Effect of tubeimoside I on the activity of cytochrome P450 enzymes in human liver microsomes
Rui Wang, Kai Zheng, Yunjiao Liu, et al.
Xenobiotica (2024) Vol. 54, Iss. 2, pp. 57-63
Open Access
Rui Wang, Kai Zheng, Yunjiao Liu, et al.
Xenobiotica (2024) Vol. 54, Iss. 2, pp. 57-63
Open Access
